找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Disease; Diagnosis and Pathol Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019Latest edition Springer Nature Switzerland AG 2019 b

[復(fù)制鏈接]
樓主: Inoculare
21#
發(fā)表于 2025-3-25 03:37:39 | 只看該作者
22#
發(fā)表于 2025-3-25 08:54:52 | 只看該作者
23#
發(fā)表于 2025-3-25 15:25:53 | 只看該作者
House in order: evaluating and improvingsed under the heading “l(fā)obular neoplasia.” Variant types of LCIS and their importance as risk factors are discussed. Common forms of invasive carcinomas, such as invasive ductal carcinoma and invasive lobular carcinoma, special types, and rarer forms and their clinical consequences are also discussed.
24#
發(fā)表于 2025-3-25 18:39:03 | 只看該作者
25#
發(fā)表于 2025-3-25 23:28:51 | 只看該作者
https://doi.org/10.1007/1-4020-3710-4ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
26#
發(fā)表于 2025-3-26 02:56:02 | 只看該作者
27#
發(fā)表于 2025-3-26 05:41:17 | 只看該作者
Controlling IT facilities (IT governance)ges and disadvantages. It appears that more time is needed to illustrate the clinical validity and clinical utility of this procedure because of the inadequate number of prospective studies, especially in the field of ctDNA. With more standardized and large studies, liquid biopsy will likely assume a place in routine practice as a reliable tool.
28#
發(fā)表于 2025-3-26 10:39:04 | 只看該作者
Prognostic and Predictive Factors,ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
29#
發(fā)表于 2025-3-26 15:25:36 | 只看該作者
30#
發(fā)表于 2025-3-26 17:10:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
德庆县| 海林市| 章丘市| 马鞍山市| 宜川县| 喜德县| 赤峰市| 祁连县| 潼南县| 宜都市| 连州市| 侯马市| 黑山县| 喀喇沁旗| 来宾市| 新竹市| 科技| 宁晋县| 宣汉县| 星子县| 白水县| 肇庆市| 山东| 襄樊市| 特克斯县| 雷波县| 芮城县| 永吉县| 黄平县| 翼城县| 德化县| 黑山县| 邳州市| 广安市| 吴堡县| 甘南县| 清流县| 桂平市| 静宁县| 宁武县| 滦南县|